3,6-Di(thiophen-2-yl)pyrrolo[3,4-c]pyrrole-1,4(2H,5H)-dione, 95.0%, 25g

3-Ethoxy-5-methyl-1H-pyrazole, 98+%, 2g

5-BROMO-6,7-DIHYDRO-1H-INDAZOL-4(5H)-ONE, 95.0%, 250mg

tert-Butyl (1-(6-bromopyridin-2-yl)cyclobutyl)carbamate, 95.0%, 1g

ethyl 3-[(1-phenylethyl)amino]propanoate, 95.0%, 10g

2-(2-Chloro-acetylamino)-4-(5-methyl-furan-2-yl)-thiophene-3-carboxylic acid ethyl ester, 95.0%, 250mg

(S)-N,N-Diisopropyldinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin-4-amine, 98.0%, 250mg

TERT-BUTYL 5-FLUOROISOINDOLINE-2-CARBOXYLATE, 95.0%, 1g

h-gln-otbu.hcl, 98.0%, 1g

4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepine-7-sulfonyl chloride, 95.0%, 1g

Flacons à fond rond à trois cols cols latéraux parallèles, 250 ml, 29/32, 19/26, 1 pièce

1-(2,3-DIFLUOROPHENYL)CYCLOPENTANECARBONITRILE, 95%, 100mg

Methyl 3-Formyl-4-hydroxybenzoate, 97.0%, 10g